dr. rebecca duerst, program director for health care elca synod malaria summit 20-22 march 2014

19
THE SCIENCE OF MALARIA: BIOLOGY, EPIDEMIOLOGY & PUBLIC HEALTH Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Upload: beverly-merritt

Post on 16-Dec-2015

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

THE SCIENCE OF MALARIA: BIOLOGY, EPIDEMIOLOGY & PUBLIC HEALTH

Dr. Rebecca Duerst, Program Director for Health Care

ELCA Synod Malaria Summit20-22 March 2014

Page 2: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Outline

True or False on malaria biology, epidemiology, and public health

Scientific advances in malaria work Time for Q&A

Page 3: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Biology, Question 1 Q: Malaria is caused

by mosquitos A: False Explanation: Malaria is

caused by parasites in the genus Plasmodium; it is transmitted by female Anopheles mosquitoes

Page 4: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Biology, Question 2 Q: There are 4 species of Plasmodia known to cause

malaria in humans A: False The 4 main species causing

human malaria are: Plasmodium falciparum Plasmodium ovale Plasmodium vivax Plasmodium malariae

A 5th species, Plasmodium knowlesi (“nolls-eye”), is now recognized as an important cause of human disease in Southeast Asia; it is responsible for up to 75% of malaria infections in some areas

Page 5: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Biology, Question 3 Q: The life cycle of Plasmodium parasites is

complex A: True http://www.cdc.gov/malaria/about/biology

a Female Anopheles mosquitoes require a blood meal for egg development. Infected females inject the sporozoite form into a human host. b Sporozoites are carried in the bloodstream to liver cells, where they proliferate asexually and release merozoites. c Merozoites invade red blood cells and reproduce asexually; disease clinically manifests as fever & chills. d Then male and female gametocytes are produced and transmitted back to a mosquito, where they fuse to form oocysts that divide into sporozoites. These migrate to the salivary glands.

Page 6: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Epidemiology, Question 1 Q: Epidemiology is the branch of

medicine dealing with physiology and pathology of the skin

A: False Epidemiology is the study of distribution

and determinants of health-related states / events (including disease), and the application of this study to control diseases and other health problems (WHO)

Page 7: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Epidemiology, Question 2 Q: Africa carries the majority of the world’s burden of

malaria A: True

Page 8: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Epidemiology, Question 3 Q: Malaria has no relationship to poverty, HIV&AIDS,

climate change, etc. A: False www.gapminder.org

Page 9: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Public Health, Question 1 Q: Despite much progress, malaria is still a major

public health concern globally A: True 2012 estimated malaria cases:

207 million 80% occur in sub-Saharan Africa

2012 estimated malaria deaths: 627,000 90% occur in sub-Saharan Africa, 77% in children under

5 years of age An estimated 3.3 million deaths were averted

between 2000-2012

Page 10: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Public Health, Question 2 Q: Focusing efforts only on net

distribution is the best strategy for malaria prevention

A: False WHO promotes integrated approach

(“integrated vector management”) including LLINs, IRS, & environmental management, along with education, prompt diagnosis and effective treatment, surveillance, etc.

http://www.npr.org/blogs/health/2014/01/03/257627285/why-ending-malaria-may-be-more-about-backhoes-than-bed-nets

Page 11: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Public Health, Question 3 Q: Artemisinin (key ingredient in ACT) is

still 100% effective throughout the world A: False Parasite resistance to artemisinins has

been detected in 4 countries in Southeast Asia Cambodia, Myanmar, Thailand and Viet Nam

In Cambodia, resistance has been found to both components of ACT Special provisions have been made for DOT

with a non-artemisinin-based combination

Page 12: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

True or False?Final Question Q: Because malaria is such a focus of global health efforts,

extensive, accurate data is available A: False There is more uncertainty about malaria than any other

disease Malaria surveillance systems detect <10% of estimated

cases - Richard Cibulskis, WHO Global Malaria Programme, 2011

Page 13: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

SCIENTIFIC ADVANCES IN MALARIA RESEARCH

New ideas & technological innovations

Page 14: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Testing & Diagnosis:Detection methods Phone camera microscopes

“CellScope” (relatively expensive) 1mm glass ball, cardboard, tape

“Origami” microscope (6 March 2014) http://youtu.be/pBjIYB5Yk2I

Page 15: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Testing & Diagnosis:Detection methods “Matibabu” blood scanner (Swahili for “medical

center”) http://

news.discovery.com/tech/videos/phone-app-diagnoses-malaria-video.htm

Brian Gitta, Makerere University, Uganda pitches his idea that uses cell phones and light – not needles and blood samples to test for malaria (USAID).

Page 16: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Malaria vaccinePrime candidates PfSPZ (Sanaria) – August, 2013

6 volunteers received 5 IV doses each, over 20 weeks 100% protection, but impractical conditions

RTS,S (GSK) – October, 2013 (18 mo. follow-up) Protection lasted over 18 months, though waned

slightly Reduced malaria cases in children by nearly half (46%) Adding a booster dose at 18 months is now being studied Policy recommendation from WHO is possible in 2015

http://www.npr.org/blogs/health/2013/10/08/230356317/first-malaria-vaccine-moves-a-step-closer-to-approval

Page 17: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

DrugsNew targets? AP2-G protein – February, 2014

Master switch that triggers activation of genes that initiate the development of gametocytes (only form infectious to mosquitos)

CAX protein – April, 2013 Transporter that controls calcium

level inside cells (Artemisinin interferes with the other Ca+2 transporter)

Parasites die before developing inside mosquito when CAX does not function

Page 18: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

MosquitosAltering the vector GM mosquitos (?)

Mosquito blood has proteins that punch holes through the parasite’s membrane

Engineer mosquitos that produce in higher amounts

Wolbachia-infected mosquitos Bacteria naturally occuring in

other species of mosquitos Confers resistance to malaria

(and dengue virus)

Page 19: Dr. Rebecca Duerst, Program Director for Health Care ELCA Synod Malaria Summit 20-22 March 2014

Thank you!